Ideaya Biosciences Inc’s recent filing unveils that its President and CEO Hata Yujiro S unloaded Company’s shares for reported $1.07 million on Feb 09 ’24. In the deal valued at $45.54 per share,23,557 shares were sold. As a result of this transaction, Hata Yujiro S now holds 677,887 shares worth roughly $27.91 million.
Then, Ruiz Briseno Andres sold 2,000 shares, generating $92,045 in total proceeds. Upon selling the shares at $46.02, the insider now owns 24,531 shares.
Before that, Hata Yujiro S sold 75,815 shares. Ideaya Biosciences Inc shares valued at $3,422,835 were divested by the President and CEO at a price of $45.15 per share. As a result of the transaction, Hata Yujiro S now holds 677,887 shares, worth roughly $27.91 million.
BTIG Research initiated its Ideaya Biosciences Inc [IDYA] rating to a Buy in a research note published on March 08, 2024; the price target was $55. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in early August with a ‘”an Outperform”‘ rating. Goldman began covering IDYA with “Buy” recommendation on May 24, 2023. Stifel revised its rating on April 24, 2023. It rated IDYA as “a Buy” which previously was an “a Hold”.
Price Performance Review of IDYA
On Tuesday, Ideaya Biosciences Inc [NASDAQ:IDYA] saw its stock fall -0.82% to $41.17. Over the last five days, the stock has lost -3.29%. Ideaya Biosciences Inc shares have risen nearly 15.71% since the year began. Nevertheless, the stocks have risen 198.33% over the past one year. While a 52-week high of $47.74 was reached on 02/15/24, a 52-week low of $13.81 was recorded on 01/05/24. SMA at 50 days reached $44.17, while 200 days put it at $33.15. A total of 0.4 million shares were traded, compared to the trading of 0.34 million shares in the previous session.
Levels Of Support And Resistance For IDYA Stock
The 24-hour chart illustrates a support level at 40.64, which if violated will result in even more drops to 40.10. On the upside, there is a resistance level at 41.88. A further resistance level may holdings at 42.59. The Relative Strength Index (RSI) on the 14-day chart is 42.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.76%. Stochastics %K at 23.94% indicates the stock is a holding.
The most recent change occurred on March 23, 2023 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $26 price target.
